FOXO3 and neoplasm: Notably, overexpression of FOXO3 in the METTL3‐knockdown Hepa1‐6 cells rescued the sorafenib sensitivity effect, as reflected by the significant decrease of tumor size and tumor weight comparing to the groups treated with solvents (Fig 6F–H).